康芝药业(300086.SZ)：控股股东拟协议转让5.0004%股份

Core Viewpoint - Kangzhi Pharmaceutical (300086.SZ) announced a share transfer agreement involving 5.0004% of its total shares, indicating a strategic move by its controlling shareholder, Hongshi Investment [1] Group 1: Share Transfer Details - Hongshi Investment notified the company on September 9, 2025, about the signing of a share transfer agreement with Chenle Jiaxiang No. 4 [1] - The agreement involves the transfer of 22,758,000 unrestricted circulating shares, representing 5.0004% of the company's total shares [1] - The transfer price is set at 5.34 RMB per share, totaling approximately 121.52772 million RMB for the entire transaction [1]